Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns 
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S. 
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results 
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 
U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs 
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal 
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition 
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio 
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips 
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal 
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth 
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push 
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek 
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand 
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds 
ALBANY, N.Y., May 09, 2017 -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Michael C. Greiner, Executive Vice President and Chief Financial Officer, is scheduled to present at the 2017 UBS Global Healthcare Conference on Monday, May 22, 2017, at 8:30 a.m. ET. The conference will be held at the Grand Hyatt in New York.
A live audio and/or webcast and subsequent archived replay of AngioDynamics’ session may be accessed via the investor relations section of the Company’s website under “Events & Presentations” at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.
Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
Contact Information: Caitlin Stefanik (518) 795-1418 [email protected]
